Correlation Between MediciNova and Pharvaris

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MediciNova and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Pharvaris BV, you can compare the effects of market volatilities on MediciNova and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Pharvaris.

Diversification Opportunities for MediciNova and Pharvaris

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between MediciNova and Pharvaris is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of MediciNova i.e., MediciNova and Pharvaris go up and down completely randomly.

Pair Corralation between MediciNova and Pharvaris

Given the investment horizon of 90 days MediciNova is expected to generate 2.63 times more return on investment than Pharvaris. However, MediciNova is 2.63 times more volatile than Pharvaris BV. It trades about 0.1 of its potential returns per unit of risk. Pharvaris BV is currently generating about -0.03 per unit of risk. If you would invest  173.00  in MediciNova on August 24, 2024 and sell it today you would earn a total of  27.00  from holding MediciNova or generate 15.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MediciNova  vs.  Pharvaris BV

 Performance 
       Timeline  
MediciNova 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.
Pharvaris BV 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.

MediciNova and Pharvaris Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MediciNova and Pharvaris

The main advantage of trading using opposite MediciNova and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.
The idea behind MediciNova and Pharvaris BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum